CN110029041B - 基因检测芯片区域设计装置 - Google Patents
基因检测芯片区域设计装置 Download PDFInfo
- Publication number
- CN110029041B CN110029041B CN201810255892.8A CN201810255892A CN110029041B CN 110029041 B CN110029041 B CN 110029041B CN 201810255892 A CN201810255892 A CN 201810255892A CN 110029041 B CN110029041 B CN 110029041B
- Authority
- CN
- China
- Prior art keywords
- exon
- gene
- patients
- exons
- selecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 56
- 238000001514 detection method Methods 0.000 title claims abstract description 19
- 238000013461 design Methods 0.000 title abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 5
- 230000035772 mutation Effects 0.000 claims description 19
- 108700024394 Exon Proteins 0.000 claims description 18
- 230000004927 fusion Effects 0.000 claims description 9
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 7
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 7
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 claims description 4
- 239000000523 sample Substances 0.000 claims description 3
- 101000686031 Homo sapiens Proto-oncogene tyrosine-protein kinase ROS Proteins 0.000 claims description 2
- 102100023347 Proto-oncogene tyrosine-protein kinase ROS Human genes 0.000 claims description 2
- 230000037437 driver mutation Effects 0.000 claims description 2
- 238000011160 research Methods 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 6
- 206010069754 Acquired gene mutation Diseases 0.000 description 5
- 230000037439 somatic mutation Effects 0.000 description 5
- 230000036438 mutation frequency Effects 0.000 description 3
- 238000007481 next generation sequencing Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- 101150039808 Egfr gene Proteins 0.000 description 1
- 101000984753 Homo sapiens Serine/threonine-protein kinase B-raf Proteins 0.000 description 1
- 101150105104 Kras gene Proteins 0.000 description 1
- 102100027103 Serine/threonine-protein kinase B-raf Human genes 0.000 description 1
- 101150080074 TP53 gene Proteins 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 108700021358 erbB-1 Genes Proteins 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108700025694 p53 Genes Proteins 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810028456 | 2018-01-12 | ||
CN2018100284567 | 2018-01-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110029041A CN110029041A (zh) | 2019-07-19 |
CN110029041B true CN110029041B (zh) | 2022-07-12 |
Family
ID=67234593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810255892.8A Active CN110029041B (zh) | 2018-01-12 | 2018-03-27 | 基因检测芯片区域设计装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110029041B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105063208A (zh) * | 2015-08-10 | 2015-11-18 | 北京吉因加科技有限公司 | 一种血浆中游离的目标dna低频突变富集测序方法 |
CN105550538A (zh) * | 2016-02-03 | 2016-05-04 | 苏州大学 | 一种人类基因启动子识别方法和系统 |
CN106570349A (zh) * | 2016-10-28 | 2017-04-19 | 深圳华大基因科技服务有限公司 | 用于目标区域捕获高通量测序的特异性肿瘤探针区域设计方法和装置以及探针 |
CN106919808A (zh) * | 2017-02-28 | 2017-07-04 | 哈尔滨工业大学深圳研究生院 | 基于变步长最小均方误差自适应滤波器的基因识别系统 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100601937B1 (ko) * | 2003-12-26 | 2006-07-14 | 삼성전자주식회사 | 분별 프로브와 암플리콘 프로브가 고정화되어 있는 dna칩을 이용하여 유전자형을 판별하는 강건한 방법 및 이에사용되는 dna 칩 |
US8997034B2 (en) * | 2012-07-30 | 2015-03-31 | Synopsys, Inc. | Emulation-based functional qualification |
-
2018
- 2018-03-27 CN CN201810255892.8A patent/CN110029041B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105063208A (zh) * | 2015-08-10 | 2015-11-18 | 北京吉因加科技有限公司 | 一种血浆中游离的目标dna低频突变富集测序方法 |
CN105550538A (zh) * | 2016-02-03 | 2016-05-04 | 苏州大学 | 一种人类基因启动子识别方法和系统 |
CN106570349A (zh) * | 2016-10-28 | 2017-04-19 | 深圳华大基因科技服务有限公司 | 用于目标区域捕获高通量测序的特异性肿瘤探针区域设计方法和装置以及探针 |
CN106919808A (zh) * | 2017-02-28 | 2017-07-04 | 哈尔滨工业大学深圳研究生院 | 基于变步长最小均方误差自适应滤波器的基因识别系统 |
Non-Patent Citations (1)
Title |
---|
TP53、KRAS和EGFR基因在非小细胞肺癌顺铂辅助化疗中肿瘤标记物的研究;孙海基;《中国博士学位论文全文数据库 (医药卫生科技辑)》;20090915(第09期);E072-14 * |
Also Published As
Publication number | Publication date |
---|---|
CN110029041A (zh) | 2019-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jia et al. | Mining TCGA database for genes of prognostic value in glioblastoma microenvironment | |
Timar et al. | Molecular epidemiology and diagnostics of KRAS mutations in human cancer | |
Zhu et al. | A long non-coding RNA signature to improve prognosis prediction of gastric cancer | |
Simbolo et al. | Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin‐remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D | |
Tan et al. | Genomic alteration during metastasis of lung adenocarcinoma | |
Lerner et al. | Bladder cancer molecular taxonomy: summary from a consensus meeting | |
Daemen et al. | Modeling precision treatment of breast cancer | |
EP2536854B1 (en) | Personalized tumor biomarkers | |
Comtesse et al. | Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26‐27 in squamous cell carcinoma of the lung | |
Jabs et al. | Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer | |
Antonov et al. | PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome | |
Smeets et al. | Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis | |
van Beers et al. | Array-CGH and breast cancer | |
Fekete et al. | Meta‐analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples | |
Alvi et al. | Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility | |
Regner et al. | A multi-omic single-cell landscape of human gynecologic malignancies | |
Jesinghaus et al. | Genotyping of colorectal cancer for cancer precision medicine: results from the IPH Center for Molecular Pathology | |
Evelönn et al. | DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma | |
Oshi et al. | Immune cytolytic activity is associated with reduced intra-tumoral genetic heterogeneity and with better clinical outcomes in triple negative breast cancer | |
Georgescu et al. | Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genes | |
Bucher-Johannessen et al. | Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome | |
Kim et al. | PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma | |
Wang et al. | Tumor evolution of glioma intrinsic gene expression subtype associates with immunological changes in the microenvironment | |
Liang et al. | Expression of KIF23 and its prognostic role in non-small cell lung cancer: analysis based on the data-mining of Oncomine | |
CN110029041B (zh) | 基因检测芯片区域设计装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220608 Address after: 322000 1st floor, building 9, standard workshop, No.10 Gaoxin Road, Houjiang street, Yiwu City, Jinhua City, Zhejiang Province Applicant after: ZHEJIANG ANNOROAD BIO-TECHNOLOGY Co.,Ltd. Applicant after: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. Applicant after: ANNOROAD (YIWU) MEDICAL INSPECTION CO.,LTD. Address before: Room 701, unit 2, building 8, yard 88, Kechuang 6th Street, Daxing District, Beijing 100176 Applicant before: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240618 Address after: Room 701, unit 2, building 8, yard 88, Kechuang 6th Street, Daxing District, Beijing 100176 Patentee after: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. Country or region after: China Patentee after: BEIJING ANNOROAD MEDICAL LABORATORY Co.,Ltd. Address before: 322000 1st floor, building 9, standard workshop, No.10 Gaoxin Road, Houjiang street, Yiwu City, Jinhua City, Zhejiang Province Patentee before: ZHEJIANG ANNOROAD BIO-TECHNOLOGY Co.,Ltd. Country or region before: China Patentee before: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. Patentee before: ANNOROAD (YIWU) MEDICAL INSPECTION CO.,LTD. |